Skip to main content

MYGN

Myriad Genetics Inc

Company with tickers: MYGN

CIK
899923
CUSIP
62855J104
Shares Outstanding
94,448,210
Investor Relations
https://investor.myriad.com/
13F Activity (30d)
57 filings 54 filers

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$200,000,000
as of 2016-06-30 · not restated in filings since 2023-11-07
Remaining Authorization
$110,700,000
as of 2023-09-30 · not restated in filings since 2023-11-07
Fiscal Year Ended Cash Spent
2021-12-31 $0
2020-06-30 $0
2019-06-30 $50,000,000
2018-06-30 $0
2017-06-30 $31,600,000
2016-06-30 $162,600,000
2015-06-30 $210,700,000
2014-06-30 $287,700,000
2013-06-30 $146,300,000
2012-06-30 $128,467,000
2011-06-30 $200,490,000
2010-06-30 $71,393,000

Recent quarters

Quarter Ended Cash Spent
2019-06-30 $0 Δ
2019-03-31 $0 Δ
2017-06-30 $0 Δ
2017-03-31 $0 Δ
2016-12-31 $10,300,000 Δ
2016-09-30 $21,300,000
2016-06-30 $54,700,000 Δ
2016-03-31 $45,000,000 Δ
2015-12-31 $24,900,000 Δ
2015-09-30 $38,000,000
2015-06-30 $44,800,000 Δ
2015-03-31 $62,000,000 Δ